Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial - Archive ouverte HAL Access content directly
Journal Articles The Lancet Respiratory Medicine Year : 2023

Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial

Fatima Chorfa
  • Function : Author
Mehdi Mezidi
Loredana Baboi
  • Function : Author
Gaël Bourdin
  • Function : Author
Emmanuel Vivier
  • Function : Author
Audrey Large
  • Function : Author
Pierre Donze
  • Function : Author
Radhia Bouzgarrou
  • Function : Author
Sophie Perinel Ragey
  • Function : Author
Caroline Chaudier
  • Function : Author
Olivier Desebbe
  • Function : Author
Laure Folliet
  • Function : Author
Louis Chauvelot
  • Function : Author
Paul Chabert
  • Function : Author
Guillaume David
  • Function : Author
William Danjou
  • Function : Author
Clotilde Bettinger
  • Function : Author
Pauline Bernon
  • Function : Author
Francois Dhelft
  • Function : Author
Martin Cour
  • Function : Author
Marie Simon
  • Function : Author
Thomas Baudry
  • Function : Author
Thomas Rimmele
  • Function : Author
Jean-François Carabalona
  • Function : Author
Arnaud Gregoire
  • Function : Author
Arnaud Friggeri
  • Function : Author
Donatien De-Marignan
  • Function : Author
Sylvain Roche
  • Function : Author

Dates and versions

hal-04382529 , version 1 (09-01-2024)

Identifiers

Cite

Jean-Christophe Richard, Nicolas Terzi, Hodane Yonis, Fatima Chorfa, Florent Wallet, et al.. Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial. The Lancet Respiratory Medicine, 2023, 11 (11), pp.991-1002. ⟨10.1016/S2213-2600(23)00221-7⟩. ⟨hal-04382529⟩
82 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More